RCEL - AVITA Medical, Inc.
IEX Last Trade
13.67
0.565 4.133%
Share volume: 7,865
Last Updated: Fri 27 Dec 2024 02:30:18 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.22%
PREVIOUS CLOSE
CHG
CHG%
$13.10
0.57
4.31%
Summary score
25%
Profitability
25%
Dept financing
9%
Liquidity
75%
Performance
17%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-13.66%
Return on assets
-9.65%
Return on sales
-110.51%
Return on invested capital
108.95%
Total debt ratio
20%
Debt ratio change over timeo
-0.93%
Current Ratio
9.88%
Quick Ratio
9.6%
Cash Position Ratio
8.89%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-25.11%
Return on assets
-13.27%
Return on sales
-102.77%
Return on invested capital
1128.6%
Total debt ratio
41.18%
Debt ratio change over timeo
-0.82%
Current Ratio
6.75%
Quick Ratio
6.34%
Cash Position Ratio
5.59%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-57.29%
Return on assets
-17.67%
Return on sales
-154.95%
Return on invested capital
3995.29%
Total debt ratio
66.56%
Debt ratio change over time
-0.48%
Current Ratio
7.25%
Quick Ratio
6.64%
Cash Position Ratio
5.75%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-105.92%
Return on assets
-103.17%
Return on sales
-132.3%
Return on invested capital
132.37%
Total debt ratio
-92.73%
Debt ratio change over time
-0.93%
Current Ratio
0.4%
Quick Ratio
0.32%
Cash Position Ratio
0.2%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | RCEL | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -13.66% | 13.79% | 34.47% | 7.43% |
| Return on assets | -9.65% | 2.76% | 3.15% | 5.62% |
| Return on sales | -110.51% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | 108.95% | 2.36% | 5.39% | 19.77% |
| Profitability | 25% | 41% | 60% | 60% |
| Total debt ratio | 20% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -0.93% | 308.97% | -6.99% | 1.18% |
| Dept financing | 6% | 50% | 25% | 7% |
| Current Ratio | 6.75% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 6.34% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 5.59% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 5% | 12% | 27% |
| Short-term ratios | RCEL | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -25.11% | 13.77% | 13.25% | 3.8% |
| Return on assets | -13.27% | 2.43% | 1.89% | 3.09% |
| Return on sales | -102.77% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | 1128.6% | 2.14% | 3.39% | 9.18% |
| Profitability | 25% | 65% | 59% | 57% |
| Total debt ratio | 41.18% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -0.82% | 46.38% | -72.08% | 1.51% |
| Dept financing | 11% | 50% | 25% | 7% |
| Current Ratio | 6.75% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 6.34% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 5.59% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 8% | 21% | 51% |